EXOEASY
LIVE

Serial Number

79427537

Owner

QIAGEN GmbH

Attorney

G MATHEW LOMBARD

Filing Date

Apr 4, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EXOEASY Trademark

Serial Number: 79427537

EXOEASY is a trademark filed by QIAGEN GmbH on April 4, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently pending registration.

Owner Contact Info

QIAGEN GmbH

QIAGEN Straße 1
Hilden 40724 , DE

Entity Type: 99

Trademark Details

Filing Date

April 4, 2025

Registration Date

Not Registered

Goods & Services

Chemical, biochemical and biotechnological products for medical and veterinary purposes, namely, in vitro diagnostic reagents and preparations for medical and veterinary diagnostic use; chemical, biochemical and biotechnological products for human in-vitro diagnostic purposes, namely, in vitro diagnostic reagents and preparations for medical use; chemical, biochemical and biotechnological reagents and preparations for human in-vitro diagnostic purposes, namely, in vitro diagnostic reagents and preparations for clinical use; kits comprising chemical, biochemical and biotechnological products for human in vitro diagnostic, namely, kits comprised of in vitro diagnostic reagents and preparations for medical use; chemical, biochemical and biotechnological products for medical and pharmaceutical research, namely, in vitro diagnostic reagents and preparations for medical analytic use; kits comprising chemical products for human in-vitro diagnostic for medical or pharmaceutical purposes, namely, kits comprised of in vitro diagnostic chemical reagents and preparations for medical use; kits comprising chemical, biochemical and biotechnological products for human in vitro diagnostic for detection of pathogens, viruses and bacteria for medical or pharmaceutical purposes, namely, kits comprised of in vitro diagnostic reagents and preparations for medical use; diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purification and/or for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and their molecular constituents like proteins, lipids and nucleic acids, including DNA, RNA, mRNA, miRNA; diagnostic reagents, enzymes and buffer solutions for purification isolation and analysis of extracellular vesicles and nucleic acid for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, separating, isolating, purification and for the analysis of biopolymers, in particular extracellular vesicles and their molecular constituents like nucleic acids, proteins and lipids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, in particular for marking, separating, isolating, purification and for the analysis of biopolymers, in particular extracellular vesicles, nucleic acids, including DNA, RNA, mRNA, miRNA, proteins and lipids; diagnostic kits containing reagents, enzymes and buffer solutions for purification and isolation of extracellular vesicles and their molecular constituents and nucleic acid isolation, amplification and analysis for medical or veterinary purposes

Chemical, biochemical and biotechnological products for use in industry or research use, namely, reagents and substances for use in industry and science; chemical, biochemical and biotechnological products for non-medical purposes, namely, reagents and substances for use in industry and science; chemical, biochemical and biotechnological products for use in in-vitro-diagnostic for non-medical purposes, namely, in-vitro diagnostic reagents and substances for scientific and industrial purposes; chemical, biochemical and biotechnological products for use in scientific and laboratory research, namely, chemicals and preparations for use in industry and science; chemical, biochemical and biotechnological products for use in in-vitro diagnostic for scientific research or laboratory use, namely, in vitro diagnostic reagents and preparations for scientific purposes; chemical, biochemical and biotechnological reagents and preparations for use in scientific and laboratory research, namely chemicals for use in industry and science; kits comprising chemical, biochemical and biotechnological products, namely, substances, chemicals and preparations sold as kits for industrial and scientific purposes; kits comprising chemical, biochemical and biotechnological products, namely, diagnostic reagents and preparations sold as kits for use in in-vitro diagnostics for scientific, non-medical purposes; non-medical reagents, enzymes and chemicals, used in analytical chemistry, for scientific and medical research use for marking, separating, isolating, purification and for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and their molecular constituents like proteins, lipids and nucleic acids, including DNA, RNA, mRNA, miRNA, in particular reagents, enzymes and buffer solutions for purification, isolation and analysis of extracellular vesicles and nucleic acids; chemical test kits comprising non-medical reagents, enzymes and buffer solutions for analysis for laboratory or research use for marking, separating, isolating and/or for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and nucleic acids

Laboratory apparatus and instruments, namely for spin-column-based sample preparation and analysis; scientific apparatuses, instruments and devices, as well as their parts and components, namely, spin columns, collection tubes, tubes, pipette tips for laboratory use, chromatographic columns for laboratory use; chromatography spin columns for laboratory use; membranes for filtration for scientific laboratory use in affinity and size exclusion chromatography (SEC); chromatography spin column membranes for laboratory use; bottles and vessels being glassware and plastic consumables for laboratory use; laboratory storage and collecting test tubes; holders adapted for test tubes; downloadable software for database management, process control, full connectivity and surveillance of laboratory apparatus and instruments, protocols for purification of extracellular vesicles, exosomes, RNA, DNA, such as extracellular DNA, genomic DNA, plasmid DNA, viral nucleic acids and proteins, DNA and RNA cleanup, for use in scientific and medical research; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, namely, tubes, pipette tips, chromatographic columns, chromatography spin columns, bottles and vessels being glassware and plastic consumables, all for laboratory use; laboratory storage and collecting test tubes for use in the purification, isolation and analysis of nucleic acids, including DNA, RNA, mRNA, miRNA, and extracellular vesicles, such as exosomes, and their molecular constituents like proteins, nucleic acids and lipids; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, namely, tubes, pipette tips, chromatographic columns, chromatography spin columns, bottles and vessels being glassware and plastic consumables, all for laboratory use; laboratory storage and collecting test tubes for use in analysis and determination of quality and quantity of vesicles; laboratory filters; membranes including ultrafiltration and adsorption membranes, all being laboratory filters for laboratory apparatus; filters for biological samples, including cell cultures and their supernatants, blood and blood components for laboratory use; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, namely, tubes, pipette tips, chromatographic columns, chromatography spin columns, bottles and vessels being glassware and plastic consumables, all for laboratory use; laboratory storage and collecting test tubes for use in purification, isolation and analysis of vesicles from biological samples, in particular biofluids, including urine, serum, plasma, cerebrospinal fluid (CSF) and cell culture supernatant

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 3, 2026 GNFN
FINAL REFUSAL E-MAILED
Apr 3, 2026 GNFR
FINAL REFUSAL WRITTEN
Apr 3, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2026 TROA
REFUSAL PROCESSED BY IB
Oct 3, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 12, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 12, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 2, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 1, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 24, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 11, 2025 MAFR
APPLICATION FILING RECEIPT MAILED
Jul 11, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 10, 2025 REPR